{"id":"https://openalex.org/W3002622012","doi":"https://doi.org/10.1016/j.msard.2020.101957","title":"Satisfaction and adherence with glatiramer acetate 40mg/mL TIW in RRMS after 12 months, and the effect of switching from 20mg/mL QD","display_name":"Satisfaction and adherence with glatiramer acetate 40mg/mL TIW in RRMS after 12 months, and the effect of switching from 20mg/mL QD","publication_year":2020,"publication_date":"2020-01-20","ids":{"openalex":"https://openalex.org/W3002622012","doi":"https://doi.org/10.1016/j.msard.2020.101957","mag":"3002622012","pmid":"https://pubmed.ncbi.nlm.nih.gov/32028117"},"language":"en","primary_location":{"id":"doi:10.1016/j.msard.2020.101957","doi":"https://doi.org/10.1016/j.msard.2020.101957","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.msard.2020.101957","pdf_url":null,"source":{"id":"https://openalex.org/S2764622253","display_name":"Multiple Sclerosis and Related Disorders","issn_l":"2211-0348","issn":["2211-0348","2211-0356"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis and Related Disorders","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5036008316","display_name":"Gary Cutter","orcid":"https://orcid.org/0000-0002-8455-980X","observed_orcids":["https://orcid.org/0000-0002-8455-980X"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]},{"id":"https://openalex.org/I4210167303","display_name":"Birmingham Repertory Theatre","ror":"https://ror.org/05sa51379","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210167303"]}],"countries":["GB","US"],"is_corresponding":true,"raw_author_name":"Gary Cutter","raw_affiliation_strings":["University of Alabama at Birmingham, Ryals Public Health Building 410B, 1665 University Boulevard, Birmingham, AL 35294-0022, USA; Pythagoras, Inc., Birmingham, AL 35205, USA. Electronic address: cutterg@uab.edu","Pythagoras, Inc., Birmingham, AL 35205, USA","University of Alabama at Birmingham, Ryals Public Health Building 410B, 1665 University Boulevard, Birmingham, AL 35294-0022, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Ryals Public Health Building 410B, 1665 University Boulevard, Birmingham, AL 35294-0022, USA; Pythagoras, Inc., Birmingham, AL 35205, USA. Electronic address: cutterg@uab.edu","institution_ids":["https://openalex.org/I32389192"]},{"raw_affiliation_string":"Pythagoras, Inc., Birmingham, AL 35205, USA","institution_ids":["https://openalex.org/I4210167303"]},{"raw_affiliation_string":"University of Alabama at Birmingham, Ryals Public Health Building 410B, 1665 University Boulevard, Birmingham, AL 35294-0022, USA","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023360727","display_name":"Antonella Veneziano","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Antonella Veneziano","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109448714","display_name":"Augusto Grinspan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Augusto Grinspan","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111720362","display_name":"Mahir Al-Banna","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mahir Al-Banna","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA. Electronic address: mahir.al-banna@tevapharm.com","Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA. Electronic address: mahir.al-banna@tevapharm.com","institution_ids":[]},{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001299036","display_name":"Alexey Boy\u043a\u043e","orcid":"https://orcid.org/0000-0003-3306-9541","observed_orcids":["https://orcid.org/0000-0003-3306-9541"]},"institutions":[{"id":"https://openalex.org/I337778094","display_name":"Pirogov Russian National Research Medical University","ror":"https://ror.org/018159086","country_code":"RU","type":"education","lineage":["https://openalex.org/I337778094","https://openalex.org/I4210117042"]}],"countries":["RU"],"is_corresponding":false,"raw_author_name":"Alexey Boyko","raw_affiliation_strings":["Neuroimmunological Department at Federal Center of Cerebrovascular Pathology and Stroke, Multiple Sclerosis Center at Yusupov Hospital, Ulitsa Ostrovityanova, 1, Pirogov Russian National Research Medical University, Moscow 117997, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroimmunological Department at Federal Center of Cerebrovascular Pathology and Stroke, Multiple Sclerosis Center at Yusupov Hospital, Ulitsa Ostrovityanova, 1, Pirogov Russian National Research Medical University, Moscow 117997, Russia","institution_ids":["https://openalex.org/I337778094"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112709957","display_name":"Maria N. Zakharova","orcid":"https://orcid.org/0000-0002-1072-9968","observed_orcids":["https://orcid.org/0000-0002-1072-9968"]},"institutions":[{"id":"https://openalex.org/I4210159010","display_name":"Research Center of Neurology","ror":"https://ror.org/05b74sw86","country_code":"RU","type":"healthcare","lineage":["https://openalex.org/I4210159010"]}],"countries":["RU"],"is_corresponding":true,"raw_author_name":"Maria Zakharova","raw_affiliation_strings":["Research Center of Neurology, m. Sokol, Tushinskaya, Schukinskaya Volokolamskoe shosse, 80, Moscow 125367, Russia. Electronic address: vincera@vincera.ru","Research Center of Neurology, m. Sokol, Tushinskaya, Schukinskaya Volokolamskoe shosse, 80, Moscow 125367, Russia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research Center of Neurology, m. Sokol, Tushinskaya, Schukinskaya Volokolamskoe shosse, 80, Moscow 125367, Russia. Electronic address: vincera@vincera.ru","institution_ids":["https://openalex.org/I4210159010"]},{"raw_affiliation_string":"Research Center of Neurology, m. Sokol, Tushinskaya, Schukinskaya Volokolamskoe shosse, 80, Moscow 125367, Russia","institution_ids":["https://openalex.org/I4210159010"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110416737","display_name":"Eva Maria Maida","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Eva Maida","raw_affiliation_strings":["Multiple Sclerosis Center, Vienna, Koellnerhofgasse 4/12, 1010 Vienna, Austria. Electronic address: praxis@maida.at","Multiple Sclerosis Center, Vienna, Koellnerhofgasse 4/12, 1010 Vienna, Austria"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multiple Sclerosis Center, Vienna, Koellnerhofgasse 4/12, 1010 Vienna, Austria. Electronic address: praxis@maida.at","institution_ids":[]},{"raw_affiliation_string":"Multiple Sclerosis Center, Vienna, Koellnerhofgasse 4/12, 1010 Vienna, Austria","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010074689","display_name":"Marija Bo\u0161njak Pa\u0161i\u0107","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I138937732","display_name":"University Hospital Centre Zagreb","ror":"https://ror.org/00r9vb833","country_code":"HR","type":"healthcare","lineage":["https://openalex.org/I138937732"]},{"id":"https://openalex.org/I4210128318","display_name":"Ministry of Health","ror":"https://ror.org/03x4sv346","country_code":"HR","type":"government","lineage":["https://openalex.org/I4210128318"]},{"id":"https://openalex.org/I51314090","display_name":"University of Osijek","ror":"https://ror.org/05sw4wc49","country_code":"HR","type":"education","lineage":["https://openalex.org/I51314090"]}],"countries":["HR"],"is_corresponding":false,"raw_author_name":"Marija Bosnjak Pasic","raw_affiliation_strings":["Department of Neurology, University Hospital Centre Zagreb, School of Medicine, Josip Juraj Strossmayer University of Osijek, Trg Svetog Trojstva 3, 31000 Osijek, Croatia; Referral Centre of the Ministry of Health of the Republic of Croatia for Demyelinating Diseases of the Central Nervous System, 10000 Zagreb, Croatia","Department of Neurology, University Hospital Centre Zagreb, School of Medicine, Josip Juraj Strossmayer University of Osijek, Trg Svetog Trojstva 3, 31000 Osijek, Croatia","Referral Centre of the Ministry of Health of the Republic of Croatia for Demyelinating Diseases of the Central Nervous System, 10000 Zagreb, Croatia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, University Hospital Centre Zagreb, School of Medicine, Josip Juraj Strossmayer University of Osijek, Trg Svetog Trojstva 3, 31000 Osijek, Croatia; Referral Centre of the Ministry of Health of the Republic of Croatia for Demyelinating Diseases of the Central Nervous System, 10000 Zagreb, Croatia","institution_ids":["https://openalex.org/I138937732","https://openalex.org/I51314090"]},{"raw_affiliation_string":"Department of Neurology, University Hospital Centre Zagreb, School of Medicine, Josip Juraj Strossmayer University of Osijek, Trg Svetog Trojstva 3, 31000 Osijek, Croatia","institution_ids":["https://openalex.org/I138937732","https://openalex.org/I51314090"]},{"raw_affiliation_string":"Referral Centre of the Ministry of Health of the Republic of Croatia for Demyelinating Diseases of the Central Nervous System, 10000 Zagreb, Croatia","institution_ids":["https://openalex.org/I4210128318"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106733906","display_name":"Sanjay K Gandhi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Sanjay K. Gandhi","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA. Electronic address: sanjay.gandhi01@tevapharm.com","Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA. Electronic address: sanjay.gandhi01@tevapharm.com","institution_ids":[]},{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Robin Everts","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210139373","display_name":"Teva Pharmaceuticals (United States)","ror":"https://ror.org/03etg4523","country_code":"US","type":"company","lineage":["https://openalex.org/I4210109720","https://openalex.org/I4210139373"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Robin Everts","raw_affiliation_strings":["Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA. Electronic address: robin.everts@tevapharm.com","Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA. Electronic address: robin.everts@tevapharm.com","institution_ids":[]},{"raw_affiliation_string":"Teva Pharmaceutical Industries Ltd, 41 Moores Rd, Malvern, PA 19355, USA","institution_ids":["https://openalex.org/I4210139373"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083744505","display_name":"Cinzia Cordioli","orcid":"https://orcid.org/0000-0003-2908-8539","observed_orcids":["https://orcid.org/0000-0003-2908-8539"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cinzia Cordioli","raw_affiliation_strings":["Multiple Sclerosis Center, Montichiari Hospital, Via G. Ciotti, 154, 25018 Montichiari, Brescia, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Multiple Sclerosis Center, Montichiari Hospital, Via G. Ciotti, 154, 25018 Montichiari, Brescia, Italy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5079049956","display_name":"Silvia Rossi","orcid":"https://orcid.org/0000-0003-3257-8248","observed_orcids":["https://orcid.org/0000-0003-3257-8248"]},"institutions":[{"id":"https://openalex.org/I4210164485","display_name":"Fondazione IRCCS Istituto Neurologico Carlo Besta","ror":"https://ror.org/05rbx8m02","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4210164485"]}],"countries":["IT"],"is_corresponding":true,"raw_author_name":"Silvia Rossi","raw_affiliation_strings":["Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Giovanni Celoria, 11, 20133 Milan, Italy. Electronic address: silvia.rossi@istituto-besta.it","Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Giovanni Celoria, 11, 20133 Milan, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Giovanni Celoria, 11, 20133 Milan, Italy. Electronic address: silvia.rossi@istituto-besta.it","institution_ids":["https://openalex.org/I4210164485"]},{"raw_affiliation_string":"Neuroimmunology and Neuromuscular Diseases Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Via Giovanni Celoria, 11, 20133 Milan, Italy","institution_ids":["https://openalex.org/I4210164485"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":9,"corresponding_author_ids":["https://openalex.org/A5036008316","https://openalex.org/A5079049956","https://openalex.org/A5106733906","https://openalex.org/A5110416737","https://openalex.org/A5111720362","https://openalex.org/A5112709957"],"corresponding_institution_ids":["https://openalex.org/I32389192","https://openalex.org/I4210139373","https://openalex.org/I4210159010","https://openalex.org/I4210164485","https://openalex.org/I4210167303"],"apc_list":{"value":3050,"currency":"USD","value_usd":3050},"apc_paid":null,"fwci":0.8397,"has_fulltext":false,"cited_by_count":10,"citation_normalized_percentile":{"value":0.71087993,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":96},"biblio":{"volume":"40","issue":null,"first_page":"101957","last_page":"101957"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glatiramer-acetate","display_name":"glatiramer acetate","score":0.968999981880188},{"id":"https://openalex.org/keywords/relapsing-remitting-multiple-sclerosis","display_name":"relapsing-remitting multiple sclerosis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/patient-satisfaction","display_name":"patient satisfaction","score":0.7120000123977661},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.9570000171661377},{"id":"https://openalex.org/keywords/twice-weekly-dosing","display_name":"twice-weekly dosing","score":0.765999972820282},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.9810000061988831},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.8999999761581421},{"id":"https://openalex.org/keywords/treatment-convenience","display_name":"treatment convenience","score":0.8190000057220459},{"id":"https://openalex.org/keywords/fatigue","display_name":"fatigue","score":0.9139999747276306},{"id":"https://openalex.org/keywords/mental-health","display_name":"mental health","score":0.9559999704360962}],"concepts":[{"id":"https://openalex.org/C2778577042","wikidata":"https://www.wikidata.org/wiki/Q418274","display_name":"Glatiramer acetate","level":3,"score":0.901699960231781},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8845471143722534},{"id":"https://openalex.org/C2775944032","wikidata":"https://www.wikidata.org/wiki/Q22907659","display_name":"Patient satisfaction","level":2,"score":0.6531795859336853},{"id":"https://openalex.org/C2780640218","wikidata":"https://www.wikidata.org/wiki/Q8277","display_name":"Multiple sclerosis","level":2,"score":0.6002752780914307},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4977288544178009},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.49759939312934875},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4859972894191742},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.34287381172180176},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.2620200514793396},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.14477506279945374}],"mesh":[{"descriptor_ui":"D000068717","descriptor_name":"Glatiramer Acetate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068717","descriptor_name":"Glatiramer Acetate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068717","descriptor_name":"Glatiramer Acetate","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000068717","descriptor_name":"Glatiramer Acetate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000068717","descriptor_name":"Glatiramer Acetate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000068717","descriptor_name":"Glatiramer Acetate","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000099059","descriptor_name":"Assessment of Medication Adherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D007166","descriptor_name":"Immunosuppressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D017060","descriptor_name":"Patient Satisfaction","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D017063","descriptor_name":"Outcome Assessment, Health Care","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D017063","descriptor_name":"Outcome Assessment, Health Care","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D017063","descriptor_name":"Outcome Assessment, Health Care","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D020529","descriptor_name":"Multiple Sclerosis, Relapsing-Remitting","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D055118","descriptor_name":"Medication Adherence","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/j.msard.2020.101957","doi":"https://doi.org/10.1016/j.msard.2020.101957","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.msard.2020.101957","pdf_url":null,"source":{"id":"https://openalex.org/S2764622253","display_name":"Multiple Sclerosis and Related Disorders","issn_l":"2211-0348","issn":["2211-0348","2211-0356"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple Sclerosis and Related Disorders","raw_type":"journal-article"},{"id":"pmid:32028117","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32028117","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Multiple sclerosis and related disorders","raw_type":"Clinical Trial, Phase IV"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9940000176429749,"display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","score":0.5299999713897705,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307778","display_name":"Novartis","ror":"https://ror.org/02f9zrr09"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":23,"referenced_works":["https://openalex.org/W1580917658","https://openalex.org/W1989806530","https://openalex.org/W2005506388","https://openalex.org/W2015238396","https://openalex.org/W2025177594","https://openalex.org/W2048018021","https://openalex.org/W2056568077","https://openalex.org/W2061166054","https://openalex.org/W2097587877","https://openalex.org/W2112165124","https://openalex.org/W2122545833","https://openalex.org/W2127391795","https://openalex.org/W2133755641","https://openalex.org/W2144317224","https://openalex.org/W2154299978","https://openalex.org/W2311072866","https://openalex.org/W2326826867","https://openalex.org/W2474097887","https://openalex.org/W2560881614","https://openalex.org/W2726265683","https://openalex.org/W2804885025","https://openalex.org/W2944811127","https://openalex.org/W4366064463"],"related_works":["https://openalex.org/W2396047537","https://openalex.org/W2775342387","https://openalex.org/W2147912507","https://openalex.org/W102576517","https://openalex.org/W2010766933","https://openalex.org/W2119662385","https://openalex.org/W2084042786","https://openalex.org/W2501132648","https://openalex.org/W31195842","https://openalex.org/W2332599890"],"abstract_inverted_index":null,"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2}],"updated_date":"2026-10-11T09:32:39.932853","created_date":"2025-10-10T00:00:00"}